<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 11 Jun 2026 16:27:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  4          Aldeyra Therapeutics,     For: Jun 09  Filed by: Miller-Rich Nancy</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+Miller-Rich+Nancy/26636086.html</link>
   <description>si-local-file:///var/storage/secattach/20260611/26636086.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+Miller-Rich+Nancy/26636086.html</guid>
   <pubDate>Thu, 11 Jun 2026 16:27:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  4          Aldeyra Therapeutics,     For: Jun 09  Filed by: Miller-Rich Nancy</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+Miller-Rich+Nancy/26636086.html</link>
   <description>si-local-file:///var/storage/secattach/20260611/26636086.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+Miller-Rich+Nancy/26636086.html</guid>
   <pubDate>Thu, 11 Jun 2026 16:27:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  4          Aldeyra Therapeutics,     For: Jun 09  Filed by: Phillips Gary M.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+Phillips+Gary+M./26636062.html</link>
   <description>si-local-file:///var/storage/secattach/20260611/26636062.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+Phillips+Gary+M./26636062.html</guid>
   <pubDate>Thu, 11 Jun 2026 16:26:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  4          Aldeyra Therapeutics,     For: Jun 09  Filed by: Phillips Gary M.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+Phillips+Gary+M./26636062.html</link>
   <description>si-local-file:///var/storage/secattach/20260611/26636062.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+Phillips+Gary+M./26636062.html</guid>
   <pubDate>Thu, 11 Jun 2026 16:26:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  4          Aldeyra Therapeutics,     For: Jun 09  Filed by: DOUGLAS RICHARD</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+DOUGLAS+RICHARD/26636074.html</link>
   <description>si-local-file:///var/storage/secattach/20260611/26636074.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+DOUGLAS+RICHARD/26636074.html</guid>
   <pubDate>Thu, 11 Jun 2026 16:26:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  4          Aldeyra Therapeutics,     For: Jun 09  Filed by: DOUGLAS RICHARD</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+DOUGLAS+RICHARD/26636074.html</link>
   <description>si-local-file:///var/storage/secattach/20260611/26636074.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+DOUGLAS+RICHARD/26636074.html</guid>
   <pubDate>Thu, 11 Jun 2026 16:26:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  4          Aldeyra Therapeutics,     For: Jun 09  Filed by: Clark William D</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+Clark+William+D/26636027.html</link>
   <description>si-local-file:///var/storage/secattach/20260611/26636027.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+Clark+William+D/26636027.html</guid>
   <pubDate>Thu, 11 Jun 2026 16:24:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  4          Aldeyra Therapeutics,     For: Jun 09  Filed by: Clark William D</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+Clark+William+D/26636027.html</link>
   <description>si-local-file:///var/storage/secattach/20260611/26636027.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+Clark+William+D/26636027.html</guid>
   <pubDate>Thu, 11 Jun 2026 16:24:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  4          Aldeyra Therapeutics,     For: Jun 09  Filed by: Bronstein Ben</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+Bronstein+Ben/26635991.html</link>
   <description>si-local-file:///var/storage/secattach/20260611/26635991.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+Bronstein+Ben/26635991.html</guid>
   <pubDate>Thu, 11 Jun 2026 16:21:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  4          Aldeyra Therapeutics,     For: Jun 09  Filed by: Bronstein Ben</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+Bronstein+Ben/26635991.html</link>
   <description>si-local-file:///var/storage/secattach/20260611/26635991.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+Bronstein+Ben/26635991.html</guid>
   <pubDate>Thu, 11 Jun 2026 16:21:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  4          Aldeyra Therapeutics,     For: Jun 09  Filed by: Walker Neal</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+Walker+Neal/26635997.html</link>
   <description>si-local-file:///var/storage/secattach/20260611/26635997.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+Walker+Neal/26635997.html</guid>
   <pubDate>Thu, 11 Jun 2026 16:21:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  4          Aldeyra Therapeutics,     For: Jun 09  Filed by: Walker Neal</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+Walker+Neal/26635997.html</link>
   <description>si-local-file:///var/storage/secattach/20260611/26635997.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+Walker+Neal/26635997.html</guid>
   <pubDate>Thu, 11 Jun 2026 16:21:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  4          Aldeyra Therapeutics,     For: Jun 09  Filed by: DEPTULA-HICKS DARLENE M</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+DEPTULA-HICKS+DARLENE+M/26635933.html</link>
   <description>si-local-file:///var/storage/secattach/20260611/26635933.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+DEPTULA-HICKS+DARLENE+M/26635933.html</guid>
   <pubDate>Thu, 11 Jun 2026 16:18:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  4          Aldeyra Therapeutics,     For: Jun 09  Filed by: DEPTULA-HICKS DARLENE M</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+DEPTULA-HICKS+DARLENE+M/26635933.html</link>
   <description>si-local-file:///var/storage/secattach/20260611/26635933.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+DEPTULA-HICKS+DARLENE+M/26635933.html</guid>
   <pubDate>Thu, 11 Jun 2026 16:18:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  3          Aldeyra Therapeutics,     For: Jun 09  Filed by: DEPTULA-HICKS DARLENE M</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+DEPTULA-HICKS+DARLENE+M/26635781.html</link>
   <description>si-local-file:///var/storage/secattach/20260611/26635781.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+DEPTULA-HICKS+DARLENE+M/26635781.html</guid>
   <pubDate>Thu, 11 Jun 2026 16:13:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  3          Aldeyra Therapeutics,     For: Jun 09  Filed by: DEPTULA-HICKS DARLENE M</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+DEPTULA-HICKS+DARLENE+M/26635781.html</link>
   <description>si-local-file:///var/storage/secattach/20260611/26635781.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09++Filed+by%3A+DEPTULA-HICKS+DARLENE+M/26635781.html</guid>
   <pubDate>Thu, 11 Jun 2026 16:13:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  8-K        Aldeyra Therapeutics,     For: Jun 09</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09/26626060.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26626060.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09/26626060.html</guid>
   <pubDate>Wed, 10 Jun 2026 06:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  8-K        Aldeyra Therapeutics,     For: Jun 09</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09/26626060.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26626060.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+09/26626060.html</guid>
   <pubDate>Wed, 10 Jun 2026 06:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Aldeyra Therapeutics names Darlene Deptula-Hicks to board of directors</title>
   <link>http://www.streetinsider.com/Board+Changes/Aldeyra+Therapeutics+names+Darlene+Deptula-Hicks+to+board+of+directors/26625266.html</link>
   <description>

&lt;p&gt;Aldeyra Therapeutics Inc. (NASDAQ: ALDX) announced the appointment of Darlene Deptula-Hicks to its board of directors, according to a company statement.&lt;/p&gt;

&lt;p&gt;Deptula-Hicks brings more than 30 years of experience in public and private life science companies across therapeutics, diagnostics, medical devices, and healthcare technologies. She has held senior executive and chief financial officer positions and has experience with initial public offerings, capital raises, strategic partnerships, and merger and acquisition transactions.&lt;/p&gt;

&lt;p&gt;She currently serves as acting Chief Financial Officer of Normunity Inc., a clinical-stage biotechnology company focused on cancer therapies. Previously, she was Chief Financial Officer of F-star Therapeutics Inc. Deptula-Hicks holds an</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Aldeyra+Therapeutics+names+Darlene+Deptula-Hicks+to+board+of+directors/26625266.html</guid>
   <pubDate>Tue, 09 Jun 2026 20:30:13 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.17665662</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29390855</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216956</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02017112</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02088336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49446834</category>
   	  </item>
  <item>
   <title>Aldeyra Therapeutics names Darlene Deptula-Hicks to board of directors</title>
   <link>http://www.streetinsider.com/Board+Changes/Aldeyra+Therapeutics+names+Darlene+Deptula-Hicks+to+board+of+directors/26625266.html</link>
   <description>

&lt;p&gt;Aldeyra Therapeutics Inc. (NASDAQ: ALDX) announced the appointment of Darlene Deptula-Hicks to its board of directors, according to a company statement.&lt;/p&gt;

&lt;p&gt;Deptula-Hicks brings more than 30 years of experience in public and private life science companies across therapeutics, diagnostics, medical devices, and healthcare technologies. She has held senior executive and chief financial officer positions and has experience with initial public offerings, capital raises, strategic partnerships, and merger and acquisition transactions.&lt;/p&gt;

&lt;p&gt;She currently serves as acting Chief Financial Officer of Normunity Inc., a clinical-stage biotechnology company focused on cancer therapies. Previously, she was Chief Financial Officer of F-star Therapeutics Inc. Deptula-Hicks holds an</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Aldeyra+Therapeutics+names+Darlene+Deptula-Hicks+to+board+of+directors/26625266.html</guid>
   <pubDate>Tue, 09 Jun 2026 20:30:13 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.17665662</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29390855</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216956</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02017112</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02088336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49446834</category>
   	  </item>
  <item>
   <title>Aldeyra Therapeutics names Darlene Deptula-Hicks to board of directors</title>
   <link>http://www.streetinsider.com/Board+Changes/Aldeyra+Therapeutics+names+Darlene+Deptula-Hicks+to+board+of+directors/26625266.html</link>
   <description>

&lt;p&gt;Aldeyra Therapeutics Inc. (NASDAQ: ALDX) announced the appointment of Darlene Deptula-Hicks to its board of directors, according to a company statement.&lt;/p&gt;

&lt;p&gt;Deptula-Hicks brings more than 30 years of experience in public and private life science companies across therapeutics, diagnostics, medical devices, and healthcare technologies. She has held senior executive and chief financial officer positions and has experience with initial public offerings, capital raises, strategic partnerships, and merger and acquisition transactions.&lt;/p&gt;

&lt;p&gt;She currently serves as acting Chief Financial Officer of Normunity Inc., a clinical-stage biotechnology company focused on cancer therapies. Previously, she was Chief Financial Officer of F-star Therapeutics Inc. Deptula-Hicks holds an</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Aldeyra+Therapeutics+names+Darlene+Deptula-Hicks+to+board+of+directors/26625266.html</guid>
   <pubDate>Tue, 09 Jun 2026 20:30:13 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.17665662</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29390855</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216956</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02017112</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02088336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49446834</category>
   	  </item>
  <item>
   <title>Aldeyra Therapeutics names Darlene Deptula-Hicks to board of directors</title>
   <link>http://www.streetinsider.com/Board+Changes/Aldeyra+Therapeutics+names+Darlene+Deptula-Hicks+to+board+of+directors/26625266.html</link>
   <description>

&lt;p&gt;Aldeyra Therapeutics Inc. (NASDAQ: ALDX) announced the appointment of Darlene Deptula-Hicks to its board of directors, according to a company statement.&lt;/p&gt;

&lt;p&gt;Deptula-Hicks brings more than 30 years of experience in public and private life science companies across therapeutics, diagnostics, medical devices, and healthcare technologies. She has held senior executive and chief financial officer positions and has experience with initial public offerings, capital raises, strategic partnerships, and merger and acquisition transactions.&lt;/p&gt;

&lt;p&gt;She currently serves as acting Chief Financial Officer of Normunity Inc., a clinical-stage biotechnology company focused on cancer therapies. Previously, she was Chief Financial Officer of F-star Therapeutics Inc. Deptula-Hicks holds an</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Aldeyra+Therapeutics+names+Darlene+Deptula-Hicks+to+board+of+directors/26625266.html</guid>
   <pubDate>Tue, 09 Jun 2026 20:30:13 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.17665662</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29390855</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216956</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02017112</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02088336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49446834</category>
   	  </item>
  <item>
   <title>Aldeyra Therapeutics names Darlene Deptula-Hicks to board of directors</title>
   <link>http://www.streetinsider.com/Board+Changes/Aldeyra+Therapeutics+names+Darlene+Deptula-Hicks+to+board+of+directors/26625266.html</link>
   <description>

&lt;p&gt;Aldeyra Therapeutics Inc. (NASDAQ: ALDX) announced the appointment of Darlene Deptula-Hicks to its board of directors, according to a company statement.&lt;/p&gt;

&lt;p&gt;Deptula-Hicks brings more than 30 years of experience in public and private life science companies across therapeutics, diagnostics, medical devices, and healthcare technologies. She has held senior executive and chief financial officer positions and has experience with initial public offerings, capital raises, strategic partnerships, and merger and acquisition transactions.&lt;/p&gt;

&lt;p&gt;She currently serves as acting Chief Financial Officer of Normunity Inc., a clinical-stage biotechnology company focused on cancer therapies. Previously, she was Chief Financial Officer of F-star Therapeutics Inc. Deptula-Hicks holds an</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Aldeyra+Therapeutics+names+Darlene+Deptula-Hicks+to+board+of+directors/26625266.html</guid>
   <pubDate>Tue, 09 Jun 2026 20:30:13 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.17665662</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29390855</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216956</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02017112</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02088336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49446834</category>
   	  </item>
  <item>
   <title>Aldeyra Therapeutics names Darlene Deptula-Hicks to board of directors</title>
   <link>http://www.streetinsider.com/Board+Changes/Aldeyra+Therapeutics+names+Darlene+Deptula-Hicks+to+board+of+directors/26625266.html</link>
   <description>

&lt;p&gt;Aldeyra Therapeutics Inc. (NASDAQ: ALDX) announced the appointment of Darlene Deptula-Hicks to its board of directors, according to a company statement.&lt;/p&gt;

&lt;p&gt;Deptula-Hicks brings more than 30 years of experience in public and private life science companies across therapeutics, diagnostics, medical devices, and healthcare technologies. She has held senior executive and chief financial officer positions and has experience with initial public offerings, capital raises, strategic partnerships, and merger and acquisition transactions.&lt;/p&gt;

&lt;p&gt;She currently serves as acting Chief Financial Officer of Normunity Inc., a clinical-stage biotechnology company focused on cancer therapies. Previously, she was Chief Financial Officer of F-star Therapeutics Inc. Deptula-Hicks holds an</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Aldeyra+Therapeutics+names+Darlene+Deptula-Hicks+to+board+of+directors/26625266.html</guid>
   <pubDate>Tue, 09 Jun 2026 20:30:13 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.17665662</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29390855</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216956</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02017112</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02088336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49446834</category>
   	  </item>
  <item>
   <title>Aldeyra Therapeutics names Darlene Deptula-Hicks to board of directors</title>
   <link>http://www.streetinsider.com/Board+Changes/Aldeyra+Therapeutics+names+Darlene+Deptula-Hicks+to+board+of+directors/26625266.html</link>
   <description>

&lt;p&gt;Aldeyra Therapeutics Inc. (NASDAQ: ALDX) announced the appointment of Darlene Deptula-Hicks to its board of directors, according to a company statement.&lt;/p&gt;

&lt;p&gt;Deptula-Hicks brings more than 30 years of experience in public and private life science companies across therapeutics, diagnostics, medical devices, and healthcare technologies. She has held senior executive and chief financial officer positions and has experience with initial public offerings, capital raises, strategic partnerships, and merger and acquisition transactions.&lt;/p&gt;

&lt;p&gt;She currently serves as acting Chief Financial Officer of Normunity Inc., a clinical-stage biotechnology company focused on cancer therapies. Previously, she was Chief Financial Officer of F-star Therapeutics Inc. Deptula-Hicks holds an</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Aldeyra+Therapeutics+names+Darlene+Deptula-Hicks+to+board+of+directors/26625266.html</guid>
   <pubDate>Tue, 09 Jun 2026 20:30:13 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.17665662</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29390855</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216956</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02017112</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02088336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49446834</category>
   	  </item>
 </channel>
</rss>
